Nikolaos Kyriakos

Athens, ESYE31 11525, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up study.

Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up study.

Journal: World journal of gastroenterology

Published: July 01, 2025

Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative study.

Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative study.

Journal: European journal of gastroenterology & hepatology

Published: February 27, 2025

Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission.

Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission.

Journal: Frontiers in medicine

Published: February 25, 2025

Efficacy and safety of tofacitinib for the treatment of moderate-to-severe ulcerative colitis in biologic-naive patients.

Efficacy and safety of tofacitinib for the treatment of moderate-to-severe ulcerative colitis in biologic-naive patients.

Journal: European journal of gastroenterology & hepatology

Published: February 20, 2025

Diagnostic Yield and Outcomes of Small Bowel Capsule Endoscopy in Patients with Small Bowel Bleeding Receiving Antithrombotics.

Diagnostic Yield and Outcomes of Small Bowel Capsule Endoscopy in Patients with Small Bowel Bleeding Receiving Antithrombotics.

Journal: Diagnostics (Basel, Switzerland)

Published: April 08, 2024

Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.

Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.

Journal: Inflammatory bowel diseases

Published: December 08, 2021

ACUTE MYOPERICARDITIS IN A PATIENT WITH ULCERATIVE COLITIS AND THE ROLE OF MESALAMINE: A CASE REPORT.

ACUTE MYOPERICARDITIS IN A PATIENT WITH ULCERATIVE COLITIS AND THE ROLE OF MESALAMINE: A CASE REPORT.

Journal: Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates

Published: March 23, 2021

Helicobacter pylori, gastric microbiota and gastric cancer relationship: Unrolling the tangle.

Helicobacter pylori, gastric microbiota and gastric cancer relationship: Unrolling the tangle.

Journal: World journal of gastrointestinal oncology

Published: March 19, 2021

Prevalence of inflammatory bowel disease in young Greek Army male recruits from 2006 to 2018: a 13-year retrospective study from a tertiary center.

Prevalence of inflammatory bowel disease in young Greek Army male recruits from 2006 to 2018: a 13-year retrospective study from a tertiary center.

Journal: European journal of gastroenterology & hepatology

Published: March 03, 2021

Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.

Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.

Journal: Digestive diseases and sciences

Published: November 24, 2020

Informed consent in inflammatory bowel disease: a necessity in real-world clinical practice.

Informed consent in inflammatory bowel disease: a necessity in real-world clinical practice.

Journal: Annals of gastroenterology

Published: October 25, 2020

Correlation of registered drug packs in Greece with Maastricht V/Florence and Hellenic Helicobacter pylori infection treatment consensuses: A poor or a proper match?

Correlation of registered drug packs in Greece with Maastricht V/Florence and Hellenic Helicobacter pylori infection treatment consensuses: A poor or a proper match?

Journal: Basic & clinical pharmacology & toxicology

Published: April 02, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026